{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:11:00Z","timestamp":1790431860480,"version":"4.1.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01397","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T23:50:38Z","timestamp":1576108238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Array Comparative Genomic Hybridization Analysis Reveals Significantly Enriched Pathways in Canine Oral Melanoma"],"prefix":"10.3389","volume":"9","author":[{"given":"Ginevra","family":"Brocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ferraresso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Martinez-Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Castagnaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1354\/vp.39-6-651","article-title":"A comparative review of melanocytic neoplasms","volume":"39","author":"Smith","year":"2002","journal-title":"Vet Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/sj.onc.1206460","article-title":"Development of melanocyte precursors from the vertebrate neural crest","volume":"22","author":"Dupin","year":"2003","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/path.4204","article-title":"Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma","volume":"230","author":"Furney","year":"2013","journal-title":"J Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/path.5017","article-title":"Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets","volume":"244","author":"Lyu","year":"2018","journal-title":"J Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41467-018-08081-1","article-title":"Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma","volume":"10","author":"Wong","year":"2019","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng1215","article-title":"Chromosome aberrations in solid tumors","volume":"34","author":"Albertson","year":"2003","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/labinvest.2016.147","article-title":"Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features","volume":"97","author":"Merkel","year":"2017","journal-title":"Lab Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.6004\/jnccn.2012.0034","article-title":"Mucosal melanoma: a clinically and biologically unique disease entity","volume":"10","author":"Carvajal","year":"2012","journal-title":"J Natl Compr Cancer Netw"},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4632","article-title":"Cross-species models of human melanoma","volume":"238","author":"van der Weyden","year":"2016","journal-title":"J Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3109\/07357900009012210","article-title":"Spontaneously occurring tumors of companion animals as models for human cancer","volume":"18","author":"Vail","year":"2000","journal-title":"Cancer Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B17","first-page":"567","article-title":"Oral and pharyngeal neoplasia in the dog: a retrospective survey of 361 cases","volume":"175","author":"Todoroff","year":"1979","journal-title":"J Am Vet Med Assoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00000372-198501001-00039","article-title":"Benign and malignant melanocytic neoplasms of domestic animals","volume":"7","author":"Goldschmidt","year":"1985","journal-title":"Am J Dermatopathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1354\/vp.37-6-597","article-title":"Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases","volume":"37","author":"Ramos-Vara","year":"2000","journal-title":"Vet Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jaad.2006.06.017","article-title":"Primary mucosal melanoma","volume":"56","author":"Patrick","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/pcmr.12170","article-title":"Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas","volume":"27","author":"Gillard","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/vco.12190","article-title":"PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis","volume":"15","author":"Iussich","year":"2017","journal-title":"Vet Comp Oncol"},{"key":"B23","first-page":"817","article-title":"Of Mice and Men (and Dogs): development of a xenogeneic DNA vaccine for canine oral malignant melanoma","volume":"6","author":"Bergman","year":"2008","journal-title":"Cancer Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10577-014-9444-6","article-title":"Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization","volume":"23","author":"Poorman","year":"2015","journal-title":"Chromosome Res"},{"key":"B25","first-page":"p. 38","volume-title":"Histological Classification of Epithelial and Melanocytic Tumors of the Skin of Domestic Animals","author":"Goldschmidt","year":"1998"},{"key":"B26","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/vco.12473","article-title":"Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma","volume":"17","author":"Giannuzzi","year":"2019","journal-title":"Vet Comp Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1007589","DOI":"10.1371\/journal.pgen.1007589","article-title":"Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis","volume":"14","author":"Hendricks","year":"2018","journal-title":"PLoS Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO : a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0300985810388947","article-title":"Prognostic evaluation of Ki67 threshold value in canine oral melanoma","volume":"48","author":"Bergin","year":"2011","journal-title":"Vet Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1038\/s41598-019-42839-x","article-title":"Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression","volume":"9","author":"Bowlt Blacklock","year":"2019","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/10520295.2012.701764","article-title":"Replacing xylene with n-heptane for paraffin embedding","volume":"87","author":"Stockert","year":"2012","journal-title":"Biotech Histochem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1158\/1541-7786.MCR-07-0239","article-title":"MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers","volume":"6","author":"Forslund","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/cdd.2017.163","article-title":"p53 shades of Hippo","volume":"25","author":"Furth","year":"2018","journal-title":"Cell Death Differ"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/vco.12539","article-title":"Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma","author":"Zamboni","year":"2019","journal-title":"Vet Comp Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.1128\/MCB.13.12.7358","article-title":"Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E","volume":"13","author":"Rosenwald","year":"1993","journal-title":"Mol Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"21176","DOI":"10.1074\/jbc.270.36.21176","article-title":"Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels","volume":"270","author":"Rosenwald","year":"1995","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2004.05.024","article-title":"Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells","volume":"5","author":"Avdulov","year":"2004","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/1097-4644(20010315)80:4%3C483::aid-jcb1002%3E3.0.co;2-b","article-title":"Molecular interaction between human tumor marker protein p150, the largest subunit of elF3, and intermediate filament protein K7","volume":"80","author":"Lin","year":"2001","journal-title":"J Cell Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1038\/onc.2012.371","article-title":"Decreased eIF3e\/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells","volume":"32","author":"Gillis","year":"2013","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/sj.onc.1209495","article-title":"Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells","volume":"25","author":"Shi","year":"2006","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1054\/bjoc.2001.1828","article-title":"Identification of a 170-kDa protein over-expressed in lung cancers","volume":"84","author":"Pincheira","year":"2001","journal-title":"Br J Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0002-9440(10)64797-9","article-title":"Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas","volume":"157","author":"Rothe","year":"2000","journal-title":"Am J Pathol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0002-9440(10)65433-8","article-title":"Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer","volume":"154","author":"Nupponen","year":"1999","journal-title":"Am J Pathol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/geno.1997.4996","article-title":"The chromosome location of the human homolog of the mouse mammary tumor\u2014associated gene INT6 and its status in human breast carcinomas","volume":"46","author":"Miyazaki","year":"1997","journal-title":"Genomics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mc.20379","article-title":"Loss of the eukaryotic initiation factor 3f in pancreatic cancer","volume":"47","author":"Doldan","year":"2008","journal-title":"Mol Carcinog"},{"key":"B48","first-page":"6462","article-title":"Overexpression of eIF3e is correlated with colon tumor development and poor prognosis","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3390\/ijms15022172","article-title":"Int6\/eIF3e is essential for proliferation and survival of human glioblastoma cells","volume":"15","author":"Sesen","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/mc.20436","article-title":"Loss of the eukaryotic initiation factor 3f in melanoma","volume":"47","author":"Doldan","year":"2008","journal-title":"Mol Carcinog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/bab.1305","article-title":"Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2\/M phase arrest","volume":"62","author":"Li","year":"2015","journal-title":"Biotechnol Appl Biochem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/vco.12044","article-title":"Comparative analysis of MAPK and PI3K\/AKT pathway activation and inhibition in human and canine melanoma","volume":"13","author":"Fowles","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/pcmr.12512","article-title":"Synergistic targeted inhibition of MEK and dual PI3K\/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma","volume":"29","author":"Wei","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1053\/j.tcam.2009.02.002","article-title":"Tyrosine kinase inhibitors in veterinary medicine","volume":"24","author":"London","year":"2009","journal-title":"Top Companion Anim Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/jcp.25358","article-title":"Priming endothelial cells with a melanoma-derived extracellular matrix triggers the activation of \u03b1v\u03b23\/VEGFR2 axis","volume":"231","author":"Helal-Neto","year":"2016","journal-title":"J Cell Physiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2009.12.067","article-title":"Regulation of neural stem\/progenitor cell maintenance by PI3K and mTOR","volume":"470","author":"Sato","year":"2010","journal-title":"Neurosci Lett"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic?","volume":"27","author":"Braeuer","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1078-0432.CCR-10-2340","article-title":"An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma","volume":"17","author":"Asundi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10637-019-00832-1","article-title":"Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma","author":"Sandhu","year":"2019","journal-title":"Invest New Drugs"},{"key":"B60","first-page":"1105","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am J Pathol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1309\/VPL5R3JR7F1D6V03","article-title":"Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma","volume":"125","author":"Varney","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/0008-5472.CAN-16-0991","article-title":"ZIC5 drives melanoma aggressiveness by PDGFD-mediated activation of FAK and STAT3","volume":"77","author":"Satow","year":"2017","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/vco.12057","article-title":"A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma","volume":"11","author":"Ottnod","year":"2013","journal-title":"Vet Comp Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1292\/jvms.15-0510","article-title":"A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma","volume":"78","author":"Treggiari","year":"2016","journal-title":"J Vet Med Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jsap.12613","article-title":"Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK","volume":"58","author":"Verganti","year":"2017","journal-title":"J Small Anim Pract"},{"key":"B66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/(SICI)1097-4652(200003)182:3%3C323::AID-JCP2%3E3.0.CO;2-%23","article-title":"T-cell recognition of melanoma-associated antigens","volume":"182","author":"Castelli","year":"2000","journal-title":"J Cell Physiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/nar\/27.6.1524","article-title":"Characterization of a novel mouse cDNA, ES18, involved in apoptotic cell death of T-cells","volume":"27","author":"Park","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"18067","DOI":"10.1073\/pnas.0705814104","article-title":"ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ER\u03b1, is required for coregulator occupancy and chromatin modification","volume":"104","author":"Zou","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/labinvest.2015.140","article-title":"WNT signaling in glioblastoma and therapeutic opportunities","volume":"96","author":"Lee","year":"2016","journal-title":"Lab Investig"},{"key":"B70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","article-title":"Identification of genomic alterations in oesophageal squamous cell cancer","volume":"509","author":"Song","year":"2014","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4161\/cbt.3.1.561","article-title":"Wnt signaling and breast cancer","volume":"3","author":"Howe","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.pmbts.2016.09.010","article-title":"Wnt\/\u03b2 catenin-mediated signaling commonly altered in colorectal cancer","volume":"144","author":"Deitrick","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2017.02.008","article-title":"Revisiting the role of Wnt\/\u03b2-catenin signaling in prostate cancer","volume":"462","author":"Schneider","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12931-017-0650-6","article-title":"WNT signaling - lung cancer is no exception","volume":"18","author":"Rapp","year":"2017","journal-title":"Respir Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/bjc.2016.332","article-title":"In the Wnt-er of life: Wnt signalling in melanoma and ageing","volume":"115","author":"Kaur","year":"2016","journal-title":"Br J Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.ctsap.2007.03.004","article-title":"Canine oral melanoma","volume":"22","author":"Bergman","year":"2007","journal-title":"Clin Tech Small Anim Pract"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T23:50:42Z","timestamp":1576108242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":77,"alternative-id":["10.3389\/fonc.2019.01397"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01397","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"article-number":"1397"}}